A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors — Stella
A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(16 sites)
China
Chongqing University Cancer Hospital, Chongqing, Chongqing Municipality
Fujian Cancer Hospital, Fuzhou, Fujian
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong
Liuzhou People's Hospital, Liuchow, Guangxi
The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan
Henan Cancer Hospital, Zhengzhou, Henan
Union Hospital Tongji Medical College， Huazhong University of Science and Technology, Wuhan, Hubei
Zhongnan Hospital of Wuhan University, Wuhan, Hubei
Hunan Cancer Hospita, Changsha, Hunan
The Second Affiliated Hospital Of Nanchang University, Nanchang, Jiangxi
Linyi Cancer Hospital, Linyi, Shangdong
The First Affiliated Hospital of Xi'an Jiao Tong University, Xi’an, Shanxi
Tianjin Medical University General Hospital, Tianjin, Tianjin Municipality